Navigation Links
New Elekta Radiation Therapy Technology Takes Weeks Off of Lung Cancer Treatments
Date:9/19/2013

ATLANTA, Sept. 19, 2013 /PRNewswire/ – On September 4, Kettering Medical Center (Kettering, Ohio) became the first clinic in North America to use Elekta's Versa HD™ system to treat a patient, a 71-year-old woman with medically inoperable lung cancer.

The rapid speed of radiosurgery with Versa HD enabled Kettering physicians to reduce the number of treatment sessions for this patient from seven weeks to three days. In addition, each treatment session decreased from 40 minutes to less than 10 minutes.

"With Versa HD, we can cut total treatment times for our patients by at least three-to four-fold," says Douglas Einstein, MD, PhD, Chairman of Radiation Oncology at Kettering Medical Center. "This new technology has the potential to allow us to add more patients to the daily radiotherapy schedule, including patients with long commutes because the number of sessions could radically decrease. Just as important, the decreased treatment time per session will improve the patient experience.

"For example, lung cancer patients who receive radiosurgery may have their arms raised for a 40-minute session and that can be difficult for some patients," he adds. "The High Dose Rate mode of Versa HD allows us to shorten radiation beam delivery time and improve patient comfort in radiosurgery cases."

In 2012, an estimated 226,160 new cases of lung cancer were expected to be diagnosed in the US, representing almost 14 percent of all cancer diagnoses.[1]

"We can deliver advanced, state-of-the-art treatment with Versa HD and do it in a way that it not only effectively treats a patient's cancer, but also substantially decreases the impact of treatment on their quality of life," Dr. Einstein says.

To learn more about Versa HD, visit www.VersaHD.com.

Versa HD is not available for sale or distribution in all markets.

For further information, please contact:
Johan Andersson, Director, Investor Relations, Elekta AB
Tel: +46 702 100 451, email: johan.andersson@elekta.com  
Time zone: CET: Central European Time

Michelle Joiner, Director, Global Public Relations and Brand Management, Elekta
Tel: +1 770-670-2447, email: michelle.joiner@elekta.com
Time zone: ET: Eastern Time

About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,500 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com.

[1]  American Cancer Society. Cancer Facts and Figures, 2012.


'/>"/>
SOURCE Elekta
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Switzerlands Hopital Riviera Improves Confidence in Patient Treatment with Elektas Identify Solution
2. Elekta to Spotlight Versa HD System at 2013 ASTRO Annual Meeting
3. Elekta Introduces Groundbreaking Image Guidance Capabilities Integrated with Versa HD Cancer Treatment System
4. Johns Hopkins Kimmel Cancer Center Acquires Elekta Versa HD System
5. Elektas Leksell Gamma Knife Perfexion and Elekta Infinity Place First and Second in 2013 KLAS Radiation Therapy Report
6. Elekta to Exhibit New Versa HD Radiotherapy System at Annual Radiation Physics Conference
7. Odense Universitetshospital tilfører kræftpatienters stereotaktiske strålebehandling næsten tre gange hurtigere med Elektas Versa HD-system
8. Elekta Receives CE Marking for Clarity 4D Monitoring
9. Froedtert & The Medical College of Wisconsin Clinical Cancer Center Joins Elekta and Philips Research Consortium on MRI-Guided Radiation Therapy
10. Elektas Leksell Gamma Knife Perfexion Earns Top Rank in 2013s Best in KLAS for Radiation Therapy
11. Elekta-Equra Health Partnership to Increase South African Cancer Patients Access to Radiation Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... -- ITL Limited, ( ASX: ITD ), an innovative diversified healthcare ... ended 31 December 2016 compared with the previous corresponding period. A ... here . Highlights ... Earnings per share of 2.2 cents (Dec 2015: 1.2 ... $15.7m; up 11%) Profit before tax of $2.12m ...
(Date:2/23/2017)... Im Rahmen seiner Schlüsselwachstumsstrategie arbeitet die ... südwestlichen chinesischen Provinz Guizhou, 2017 mit dem Angebot von Anreize ... der Entwicklung einer eingebetteten Hightech-Schlüsselindustrie. Foto - ... ... ...
(Date:2/23/2017)... , Feb. 23, 2017 AcelRx Pharmaceuticals, ... on the development and commercialization of innovative therapies ... that it will release fourth quarter and yearly ... 2nd, 2017. AcelRx management will host an investment-community ... p.m. Pacific Time) on March 2 nd ...
Breaking Medicine Technology:
(Date:2/23/2017)... ... 2017 , ... Rare Disease Report®, which is the only ... Disease Day events, hosted by the Rare Disease Legislative Advocates (RDLA) on February ... e-newsletter and quarterly publication, will be conducting interviews with patients and advocates in ...
(Date:2/23/2017)... Los Angeles, CA (PRWEB) , ... February 23, 2017 , ... ... the first two episodes of WE TV’s “Mama June: From Not to Hot,” which ... of TV notable, “Mama” June Shannon, known to millions from the 2012 reality television ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... , media relations, content marketing, social media management, corporate communications, SEO and cause ... the state and in nearby New Hampshire, Massachusetts and Canada, Rosica will focus ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... will host a diverse symposium on “Doping in Sport: How the ... Sheppard Mullin Richter & Hampton LLP. The symposium will be held at Pepperdine ...
(Date:2/23/2017)... ... February 23, 2017 , ... Pink Pig Publishing ... generations converge and explore the world from different perspectives. By providing a place ... to gain understanding, increase empathy, and find greater happiness. , "Our approach ...
Breaking Medicine News(10 mins):